Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema
Diabetic retinopathy (DR) is one of the leading causes of blindness worldwide. Multiple treatment options have been used over time to attempt to modify the natural progression of the disease in both proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME). These two retinal complica...
Main Authors: | Jesus H. Gonzalez-Cortes, Victor A. Martinez-Pacheco, Jesus E. Gonzalez-Cantu, Alper Bilgic, Francesc March de Ribot, Aditya Sudhalkar, Jesus Mohamed-Hamsho, Laurent Kodjikian, Thibaud Mathis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/122 |
Similar Items
-
Widening use of dexamethasone implant for the treatment of macular edema
by: Bonfiglio V, et al.
Published: (2017-08-01) -
Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study
by: Thibaud Mathis, et al.
Published: (2022-03-01) -
Corticosteroid Treatment in Diabetic Macular Edema
by: Burcu Nurözler Tabakcı, et al.
Published: (2017-06-01) -
Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
by: Magna Vanessa Rodrigues, et al.
Published: (2023-09-01) -
Intra-Ocular Pressure Response to Dexamethasone Implant Injections in Patients with a History of Filtering Surgery: The TRABEX Study
by: Amina Rezkallah, et al.
Published: (2022-08-01)